HUIYU PHARMACEUTICAL: Shanghai Shuangsa reduced holdings by 0% in March
HUIYU PHARMACEUTICAL announced that its shareholder, Shanghai Shuangsa Enterprise Management Consulting Firm, originally planned to reduce its holdings by no more than 12.6956 million shares through centralized bidding or block trading from June 3, 2025, to August 31, 2025, with a reduction ratio not exceeding 2.997%. As of the expiration of the planned period, no reduction has been implemented, with an actual reduction of 0 shares and a reduction ratio of 0%; it currently still holds 12.6956 million shares of the company, accounting for 2.997% of the company's total share capital
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments